| Author (Corporate) | European Commission: Press and Communication Service |
|---|---|
| Series Title | Press Release |
| Series Details | IP/04/509 (21.4.04) |
| Publication Date | 21/04/2004 |
| Content Type | News |
|
The European Commission on 21 April 2004 placed seven anti-retroviral drugs on the list of medicines placed under European Union protection against trade diversion. The move is intended to enable pharmaceutical producers to significantly increase supplies of medicines at lower, so-called 'tiered' prices, to 76 developing countries, while keeping higher prices for the same items in the EU. The application was filed by GlaxoSmithKline in February 2004. |
|
| Source Link | Link to Main Source http://europa.eu/rapid/pressReleasesAction.do?reference=IP/04/509&format=HTML&rapid=0&language=EN&guiLanguage=en&display= |
| Related Links |
|
| Subject Categories | Business and Industry, Politics and International Relations |
| Countries / Regions | Europe |